Skyepharma has a number of oral projects in its development pipeline that utilise our proprietary technologies. We are currently progressing some products ourselves and they are available for licensing, whilst others are being developed by our partners.

Product PlatformCountryPrimary IndicationLicensee / PartnerFeasibilityPh
I
Ph
II
Ph
III
Filed
Pikto Oral 2014
SKP-1052WorldwideNocturnal hypoglycaemiaAvailableBlue DotBlue Dot
SKP-1056WorldwideNot disclosed (generic)HikmaBlue Dot
Soctec™WorldwideGastro-retentiveAvailableBlue Dot
Oleotec™WorldwideGastro-retentive - high payloadAvailableBlue Dot

Please contact us if you would like to discuss licensing of any of our products.

Disclaimer Masterpage